CSPC Pharmaceutical grants 9m restricted shares to employee

On September 19, 2025, CSPC Pharmaceutical Group Limited granted 9,000,000 restricted shares to an employee, representing approximately 0.078% of its total issued shares. This grant, made under the company's restricted share award scheme, comes at nil consideration, with the closing price of shares on the grant date being HK$9.94 per share.

The awarded shares will vest in four tranches between January 2026 and January 2029. Each tranche's vesting is contingent on the grantee meeting specific annual performance targets, including research and development project goals. The vesting schedule is as follows: 2,000,000 shares on January 30, 2026; 2,000,000 shares on January 30, 2027; 2,000,000 shares on January 30, 2028; and the remaining 3,000,000 shares on January 30, 2029.

The scheme includes a clawback mechanism, where unvested shares lapse if the grantee ceases employment, faces bankruptcy, or is convicted of certain offenses. CSPC Pharmaceutical stated that the grant aims to recognize the grantee's contribution and to encourage continued commitment to the group's future development by offering equity ownership. The awarded shares are funded by existing shares purchased on-market by the trustee, ensuring no new shares are allotted. Following this grant, 108,038,368 shares remain available for future grants under the scheme.